Affiliation:
1. University of Birmingham
2. Sheffield Hallam University
3. Keele University
4. The University of Queensland
Abstract
Abstract
Purpose
To develop and validate prediction models for the risk of future work absence and level of presenteeism, in adults seeking primary healthcare with musculoskeletal disorders (MSD).
Methods
Six studies from the West-Midlands and Northwest regions of England, recruiting adults consulting in primary care with MSD, and including work outcome data up to 12 months following consultation, were included for model development and internal-external cross-validation (IECV). The primary outcome was any work absence within 6 months of their consultation. Ten candidate predictors were included: age; sex; multisite pain; baseline pain score; pain duration; job type; anxiety/depression; presence of comorbidities; absence in the previous 6 months; baseline presenteeism.
Results
For the 6-month absence model, a total of 2179 participants (215 absences) were available across five studies. Calibration was promising, although varied across individual studies, with a pooled calibration slope of 0.93 (95%CI: 0.41 to 1.46) on IECV. On average, the model discriminated well between those with work absence within 6 months, and those without (IECV-pooled C-statistic 0.76, 95%CI: 0.66 to 0.86).
Conclusions
The model reasonably predicts risk of work absence within 6 months, on average, in adults consulting with MSD, and showed potential over a range of threshold outcome probabilities. This information could be useful to support shared decision-making and to target occupational health interventions at those individuals with a higher risk of absence in the 6 months following consultation. Further external validation is needed before the model’s use can be recommended or its impact on patients can be fully assessed.
Publisher
Research Square Platform LLC
Reference60 articles.
1. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019;Cieza A;Lancet,2020
2. Versus Arthritis. The state of musculoskeletal health 2021. 2021.
3. The burden of musculoskeletal conditions;Ingram M;Medicine,2018
4. Australian Institute of Health and Welfare. Disease expenditure in Australia 2018-19 2021 [Available from: https://www.aihw.gov.au/reports/health-welfare-expenditure/spending-on-diseasein-australia/contents/about.